Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Ablation + Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma
NCT07824856Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Objective Response Rate at 24 months. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT07824856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824856.